| 000 | 01576 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515110739.0 | ||
| 264 | 0 | _c20080528 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1388-9842 | ||
| 024 | 7 |
_a10.1016/j.ejheart.2007.12.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcMurray, John J V | |
| 245 | 0 | 0 |
_aHeart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. _h[electronic resource] |
| 260 |
_bEuropean journal of heart failure _cFeb 2008 |
||
| 300 |
_a149-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xepidemiology |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIrbesartan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aStroke Volume |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 700 | 1 | _aCarson, Peter E | |
| 700 | 1 | _aKomajda, Michel | |
| 700 | 1 | _aMcKelvie, Robert | |
| 700 | 1 | _aZile, Michael R | |
| 700 | 1 | _aPtaszynska, Agata | |
| 700 | 1 | _aStaiger, Christoph | |
| 700 | 1 | _aDonovan, J Mark | |
| 700 | 1 | _aMassie, Barry M | |
| 773 | 0 |
_tEuropean journal of heart failure _gvol. 10 _gno. 2 _gp. 149-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejheart.2007.12.010 _zAvailable from publisher's website |
| 999 |
_c17784316 _d17784316 |
||